Science

Multimodal oncology intelligence designed for careful validation.

The platform connects radiology, pathology, biomarkers, outcomes, and clinical context to generate insights that may support research, development, and patient-stratification questions.

Radiology ─┐
Pathology ─┼─> Feature Extraction ─> Clinical Context ─> Validated Insight
Biomarkers ┤
Outcomes ──┘

Radiological Intelligence

Machine-learning and expert-led analysis of tumor morphology, vascular relationships, disease extent, and imaging-derived prognostic features.

Digital Pathology

AI-supported analysis of H&E and related pathology data to identify tissue-level patterns associated with invasion, progression, response, and outcome.

Multimodal Prognostics

Models that connect imaging, pathology, biomarkers, and longitudinal clinical variables to improve prognostic assessment and patient stratification.

Clinical Development Intelligence

Insights that help sponsors evaluate cohort composition, treatment-effect heterogeneity, endpoint interpretation, biomarker strategy, and future trial design.

All product and clinical applications are subject to validation and applicable regulatory requirements.